Prof. Maciej Banach was an Undersecretary of State at the Ministry of Science and Higher Education of the Republic of Poland (2010-2012). He is a President of Polish Mother’s Memorial Hospital – Research Institute (PMMHRI) in Lodz, Head of Cardiovascular Research Centre at University of Zielona Gora, full Professor of Cardiology at the Medical University of Lodz (MUL) and PMMHRI and Head of Department of Hypertension at the MUL, Lodz, Poland. He is member of the Executive Committee of European Atherosclerosis Society (EAS) working as an Advisor in Matters related to European Union Relations/Contacts, and the International Atherosclerosis Society (IAS) Regional Federation Executive Committee Member for Europe. He is a Founder and Head of the Polish Lipid Association (PoLA), the Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group, and the International Lipid Expert Panel (ILEP). Prof. Banach has published over 1000 papers (number of citations >26.000, IH>70).

Contributions

How to diagnose and treat patients with metabolic syndromeLCN WebinarRebuttals: Is there a role for diet and nutrition in LDL lowering?91th EAS Congress 2023Is there a role for diet and nutrition in LDL lowering?Pro - Diet and nutrition is helpful for LDL-C lowering91th EAS Congress 2023Is there a role for diet and nutrition in LDL lowering?EAS Advanced Course - Rare Lipid Disorders - CologneWebinars on-demandA deep dive into CLEAR OUTCOMES and its implicationsWebinars on-demandEAS Advanced Course - Rare Lipid Disorders - PolandWebinars on-demandEAS Advanced Course in Rare Lipid Disorders - Polish Lipid AssociationWebinars on-demandWhy and how to implement early combination lipid lowering therapy - Discussion and Q&A90th EAS Congress 2022Why and how to implement early combination lipid lowering therapyPragmatic strategies to better implement combination therapies for very high risk patients90th EAS Congress 2022Why and how to implement early combination lipid lowering therapyThe clinical experienceIntro to Clinical LipidologyCurrent available therapies - Omega3 & fibratesIntro to Clinical LipidologyThe criticality of LDL goal attainment87th EAS Congress 2019Efficacy and safety of nutraceuticals87th EAS Congress 2019